# Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

> **NCT04957927** · PHASE4 · UNKNOWN · sponsor: **Usama Azhar** · enrollment: 60 (estimated)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

## Key facts

- **NCT ID:** NCT04957927
- **Lead sponsor:** Usama Azhar
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-12
- **Primary completion:** 2021-09-12
- **Final completion:** 2021-12-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04957927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04957927, "Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT04957927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*